Gene expression profile changes after short-activating RNA-mediated induction of endogenous pluripotency factors in human mesenchymal stem cells

Molecular Therapy Nucleic Acids

Volumn 1, Issue 8, 2012, Pages e35-

  Voutila, Jon ^a   Sætrom, Pål ^b   Mintz, Paul ^c   Sun, Guihua ^d   Alluin, Jessica ^d   Rossi, John J ^d   Habib, Nagy A ^c   Kasahara, Noriyuki ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Gene expression profiling; Mesenchymal stem cells; Pluripotency genes; RNA activation; SaRNA

Indexed keywords

EID: 84868345426     PISSN: None     EISSN: 21622531     Source Type: Journal    
DOI: 10.1038/mtna.2012.20     Document Type: Article

References (57)

1. Hannon, GJ and Rossi, JJ (2004). Unlocking the potential of the human genome with RNA interference. Nature 431: 371-378. (Pubitemid 39265678)
2. Castanotto, D and Rossi, JJ (2009). The promises and pitfalls of RNA-interference-based therapeutics. Nature 457: 426-433.
3. Moazed, D (2009). Small RNAs in transcriptional gene silencing and genome defence. Nature 457: 413-420.
4. Matzke, M, Aufsatz, W, Kanno, T, Daxinger, L, Papp, I, Mette, MF et al. (2004). Genetic analysis of RNA-mediated transcriptional gene silencing. Biochim Biophys Acta 1677: 129-141. (Pubitemid 38327097)
5. Hawkins, PG and Morris, KV (2008). RNA and transcriptional modulation of gene expression. Cell Cycle 7: 602-607. (Pubitemid 351498998)
6. Li, LC, Okino, ST, Zhao, H, Pookot, D, Place, RF, Urakami, S et al. (2006). Small dsRNAs induce transcriptional activation in human cells. Proc Natl Acad Sci USA 103: 17337-17342. (Pubitemid 44788970)
7. Janowski, BA, Younger, ST, Hardy, DB, Ram, R, Huffman, KE and Corey, DR (2007). Activating gene expression in mammalian cells with promoter-targeted duplex RNAs. Nat Chem Biol 3: 166-173.
8. Huang, V, Qin, Y, Wang, J, Wang, X, Place, RF, Lin, G et al. (2010). RNAa is conserved in mammalian cells. PLoS ONE 5: e8848.
9. Turunen, MP, Lehtola, T, Heinonen, SE, Assefa, GS, Korpisalo, P, Girnary, R et al. (2009). Efficient regulation of VEGF expression by promoter-targeted lentiviral shRNAs based on epigenetic mechanism: a novel example of epigenetherapy. Circ Res 105: 604-609.
10. Morris, KV, Santoso, S, Turner, AM, Pastori, C and Hawkins, PG (2008). Bidirectional transcription directs both transcriptional gene activation and suppression in human cells. PLoS Genet 4: e1000258.
11. Schwartz, JC, Younger, ST, Nguyen, NB, Hardy, DB, Monia, BP, Corey, DR et al. (2008). Antisense transcripts are targets for activating small RNAs. Nat Struct Mol Biol 15: 842-848.
12. Modarresi, F, Faghihi, MA, Lopez-Toledano, MA, Fatemi, RP, Magistri, M, Brothers, SP et al. (2012). Inhibition of natural antisense transcripts in vivo results in gene-specific transcriptional upregulation. Nat Biotechnol 30: 453-459.
13. Takahashi, K and Yamanaka, S (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676. (Pubitemid 44233629)
14. Takahashi, K, Tanabe, K, Ohnuki, M, Narita, M, Ichisaka, T, Tomoda, K et al. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131: 861-872. (Pubitemid 350138099)
15. Park, IH, Zhao, R, West, JA, Yabuuchi, A, Huo, H, Ince, TA et al. (2008). Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451: 141-146.
16. Wernig, M, Meissner, A, Foreman, R, Brambrink, T, Ku, M, Hochedlinger, K et al. (2007). In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448: 318-324. (Pubitemid 47080337)
17. Li, Y, McClintick, J, Zhong, L, Edenberg, HJ, Yoder, MC and Chan, RJ (2005). Murine embryonic stem cell differentiation is promoted by SOCS-3 and inhibited by the zinc finger transcription factor Klf4. Blood 105: 635-637. (Pubitemid 40070746)
18. Kim, J, Chu, J, Shen, X, Wang, J and Orkin, SH (2008). An extended transcriptional network for pluripotency of embryonic stem cells. Cell 132: 1049-1061. (Pubitemid 351381745)
19. Wernig, M, Meissner, A, Cassady, JP and Jaenisch, R (2008). c-Myc is dispensable for direct reprogramming of mouse fibroblasts. Cell Stem Cell 2: 10-12.
20. Sridharan, R, Tchieu, J, Mason, MJ, Yachechko, R, Kuoy, E, Horvath, S et al. (2009). Role of the murine reprogramming factors in the induction of pluripotency. Cell 136: 364-377.
21. Yelin, R, Dahary, D, Sorek, R, Levanon, EY, Goldstein, O, Shoshan, A et al. (2003). Widespread occurrence of antisense transcription in the human genome. Nat Biotechnol 21: 379-386. (Pubitemid 36397657)
22. Core, LJ, Waterfall, JJ and Lis, JT (2008). Nascent RNA sequencing reveals widespread pausing and divergent initiation at human promoters. Science 322: 1845-1848.
23. He, Y, Vogelstein, B, Velculescu, VE, Papadopoulos, N and Kinzler, KW (2008). The antisense transcriptomes of human cells. Science 322: 1855-1857.
24. Preker, P, Nielsen, J, Kammler, S, Lykke-Andersen, S, Christensen, MS, Mapendano, CK et al. (2008). RNA exosome depletion reveals transcription upstream of active human promoters. Science 322: 1851-1854.
25. Seila, AC, Calabrese, JM, Levine, SS, Yeo, GW, Rahl, PB, Flynn, RA et al. (2008). Divergent transcription from active promoters. Science 322: 1849-1851.
26. Saetrom, P and Snøve, O Jr (2004). A comparison of siRNA efficacy predictors. Biochem Biophys Res Commun 321: 247-253. (Pubitemid 39055631)
27. Hawkins, PG and Morris, KV (2010). Transcriptional regulation of Oct4 by a long noncoding RNA antisense to Oct4-pseudogene 5. Transcription 1: 165-175.
28. Ashburner, M, Ball, CA, Blake, JA, Botstein, D, Butler, H, Cherry, JM et al. (2000). Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25: 25-29. (Pubitemid 30257031)
29. Dennis, G Jr, Sherman, BT, Hosack, DA, Yang, J, Gao, W, Lane, HC et al. (2003). DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 4: P3.
30. Huang, da W, Sherman, BT and Lempicki, RA (2009). Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57.
31. Evans, PM and Liu, C (2008). Roles of Krüpel-like factor 4 in normal homeostasis, cancer and stem cells. Acta Biochim Biophys Sin (Shanghai) 40: 554-564. (Pubitemid 352009081)
32. Zeller, KI, Jegga, AG, Aronow, BJ, O'Donnell, KA and Dang, CV (2003). An integrated database of genes responsive to the Myc oncogenic transcription factor: identification of direct genomic targets. Genome Biol 4: R69.
33. Napoli, S, Pastori, C, Magistri, M, Carbone, GM and Catapano, CV (2009). Promoterspecific transcriptional interference and c-myc gene silencing by siRNAs in human cells. EMBO J 28: 1708-1719.
34. Celano, P, Berchtold, CM, Kizer, DL, Weeraratna, A, Nelkin, BD, Baylin, SB et al. (1992). Characterization of an endogenous RNA transcript with homology to the antisense strand of the human c-myc gene. J Biol Chem 267: 15092-15096.
35. Cauffman, G, Liebaers, I, Van Steirteghem, A and Van de Velde, H (2006). POU5F1 isoforms show different expression patterns in human embryonic stem cells and preimplantation embryos. Stem Cells 24: 2685-2691. (Pubitemid 46053006)
36. Zhu, S, Tai, C, MacVicar, BA, Jia, W and Cynader, MS (2009). Glutamatergic stimulation triggers rapid Krüpple-like factor 4 expression in neurons and the overexpression of KLF4 sensitizes neurons to NMDA-induced caspase-3 activity. Brain Res 1250: 49-62.
37. Wassmann, S, Wassmann, K, Jung, A, Velten, M, Knuefermann, P, Petoumenos, V et al. (2007). Induction of p53 by GKLF is essential for inhibition of proliferation of vascular smooth muscle cells. J Mol Cell Cardiol 43: 301-307. (Pubitemid 47301935)
38. Felsher, DW, Zetterberg, A, Zhu, J, Tlsty, T and Bishop, JM (2000). Overexpression of MYC causes p53-dependent G2 arrest of normal fibroblasts. Proc Natl Acad Sci USA 97: 10544-10548.
39. Marión, RM, Strati, K, Li, H, Murga, M, Blanco, R, Ortega, S et al. (2009). A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity. Nature 460: 1149-1153.
40. Wang, W, Lin, C, Lu, D, Ning, Z, Cox, T, Melvin, D et al. (2008). Chromosomal transposition of PiggyBac in mouse embryonic stem cells. Proc Natl Acad Sci USA 105: 9290-9295.
41. Sato, T, Onai, N, Yoshihara, H, Arai, F, Suda, T and Ohteki, T (2009). Interferon regulatory factor-2 protects quiescent hematopoietic stem cells from type I interferon-dependent exhaustion. Nat Med 15: 696-700.
42. Reynolds, A, Anderson, EM, Vermeulen, A, Fedorov, Y, Robinson, K, Leake, D et al. (2006). Induction of the interferon response by siRNA is cell type- and duplex lengthdependent. RNA 12: 988-993. (Pubitemid 43788117)
43. Fackler, OT and Kräusslich, HG (2006). Interactions of human retroviruses with the host cell cytoskeleton. Curr Opin Microbiol 9: 409-415. (Pubitemid 44108721)
44. Poggi, A and Zocchi, MR (2006). HIV-1 Tat triggers TGF-β production and NK cell apoptosis that is prevented by pertussis toxin B. Clin Dev Immunol 13: 369-372. (Pubitemid 44950053)
45. Reinhold, D, Wrenger, S, Kähne, T and Ansorge, S (1999). HIV-1 Tat: immunosuppression via TGF-beta1 induction. Immunol Today 20: 384-385.
46. Mandal, S, Johnson, KR and Wheelock, MJ (2008). TGF-beta induces formation of F-actin cores and matrix degradation in human breast cancer cells via distinct signaling pathways. Exp Cell Res 314: 3478-3493.
47. Mercer, J and Helenius, A (2009). Virus entry by macropinocytosis. Nat Cell Biol 11: 510-520.
48. Maréchal, V, Prevost, MC, Petit, C, Perret, E, Heard, JM and Schwartz, O (2001). Human immunodeficiency virus type 1 entry into macrophages mediated by macropinocytosis. J Virol 75: 11166-11177. (Pubitemid 33031583)
49. Wadia, JS, Stan, RV and Dowdy, SF (2004). Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat Med 10: 310-315. (Pubitemid 38667624)
50. Stadtfeld, M, Maherali, N, Breault, DT and Hochedlinger, K (2008). Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse. Cell Stem Cell 2: 230-240.
51. Brambrink, T, Foreman, R, Welstead, GG, Lengner, CJ, Wernig, M, Suh, H et al. (2008). Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells. Cell Stem Cell 2: 151-159. (Pubitemid 351168714)
52. Okita, K, Nakagawa, M, Hyenjong, H, Ichisaka, T and Yamanaka, S (2008). Generation of mouse induced pluripotent stem cells without viral vectors. Science 322: 949-953.
53. Okita, K, Ichisaka, T and Yamanaka, S (2007). Generation of germline-competent induced pluripotent stem cells. Nature 448: 313-317. (Pubitemid 47080336)
54. Papapetrou, EP, Tomishima, MJ, Chambers, SM, Mica, Y, Reed, E, Menon, J et al. (2009). Stoichiometric and temporal requirements of Oct4, Sox2, Klf4, and c-Myc expression for efficient human iPSC induction and differentiation. Proc Natl Acad Sci USA 106: 12759-12764.
55. Wang, J, Place, RF, Huang, V, Wang, X, Noonan, EJ, Magyar, CE et al. (2010). Prognostic value and function of KLF4 in prostate cancer: RNAa and vector-mediated overexpression identify KLF4 as an inhibitor of tumor cell growth and migration. Cancer Res 70: 10182-10191.
56. Lowry, WE, Richter, L, Yachechko, R, Pyle, AD, Tchieu, J, Sridharan, R et al. (2008). Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc Natl Acad Sci USA 105: 2883-2888. (Pubitemid 351723638)
57. Yu, J, Vodyanik, MA, Smuga-Otto, K, Antosiewicz-Bourget, J, Frane, JL, Tian, S et al. (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science 318: 1917-1920.